Application segmentation in the Tangential Flow Filtration with Hollow Fiber Devices market delineates five primary end‑use categories: biopharmaceutical protein purification, vaccine manufacturing, cell‑therapy processing, diagnostic reagent preparation, and industrial biotechnology. The biopharmaceutical segment, accounting for roughly 45 % of revenue, drives demand for high‑flux hollow‑fiber modules that meet stringent GMP criteria and support large‑scale monoclonal antibody capture. Vaccine manufacturing contributes about 20 % of the market, where rapid turnover and sterility are critical, prompting adoption of disposable hollow‑fiber cartridges. Cell‑therapy processing, representing 15 % of sales, requires closed‑system designs to maintain cell viability during concentration and washing steps. Diagnostic reagent preparation, at 12 % share, leverages low‑volume, high‑purity filtration for assay development. Industrial biotechnology, the remaining 8 %, utilizes robust fibers for enzyme and metabolite recovery in bulk fermentations. Collectively, these application segments define the overall market size and shape equipment specifications, capacity planning, and pricing dynamics. The phrase Tangential Flow Filtration with Hollow Fiber Devices segmentation underscores the analytical breakdown.